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In Brief
Siegert et al. find that the microbial cell
wall component LPS reduces cytosolic
free iron availability via induction of
ferritin. Low free iron levels impair the
prolyl hydroxylase domain enzyme (PHD)
activity, thereby inhibiting hypoxia-
inducible factor (HIF)-1a hydroxylation.
This results in inflammatory HIF1a
stabilization under normoxic conditions.
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Both hypoxic and inflammatory conditions activate
transcription factors such as hypoxia-inducible fac-
tor (HIF)-1a and nuclear factor (NF)-kB, which play
a crucial role in adaptive responses to these chal-
lenges. In dendritic cells (DC), lipopolysaccharide
(LPS)-induced HIF1a accumulation requires NF-kB
signaling and promotes inflammatory DC function.
The mechanisms that drive LPS-induced HIF1a
accumulation under normoxia are unclear. Here, we
demonstrate that LPS inhibits prolyl hydroxylase
domain enzyme (PHD) activity and thereby blocks
HIF1a degradation. Of note, LPS-induced PHD inhi-
bition was neither due to cosubstrate depletion (oxy-
gen or a-ketoglutarate) nor due to increased levels of
reactive oxygen species, fumarate, and succinate.
Instead, LPS inhibited PHD activity through NF-kB-
mediated induction of the iron storage protein ferritin
and subsequent decrease of intracellular available2048 Cell Reports 13, 2048–2055, December 15, 2015 ª2015 The Auiron, a critical cofactor of PHD. Thus, hypoxia and
LPS both induce HIF1a accumulation via PHD inhibi-
tion but deploy distinct molecular mechanisms (lack
of cosubstrate oxygen versus deprivation of co-fac-
tor iron).
INTRODUCTION
Hypoxia-inducible transcription factors (HIFs) are essential for
cellular adaptation to low oxygen microenvironments. The oxy-
gen-dependent regulation of HIF-1a (HIF1a) stabilization in-
volves hypoxic inhibition of prolyl hydroxylase domain enzyme
(PHD) activity, leading to impaired post-translational HIF1a hy-
droxylation at proline 402 (P402) and proline 564 (P564) in the ox-
ygen-dependent degradation (ODD) domain. This diminishes
VHL (von Hippel-Lindau tumor suppressor)-dependent HIF1a
ubiquitination and proteasomal degradation (reviewed in Kaelin
and Ratcliffe, 2008; Semenza, 2012). In addition to hypoxia, a
variety of pathogen-derived molecules and inflammatory media-
tors are able to stabilize HIF1a under normoxic conditions (re-
viewed in Palazon et al., 2014). Inmacrophages, HIF1a promotesthors
Figure 1. LPS-Induced HIF1a Stabilization Requires Hif1a mRNA
and Additional Posttranslational Processes
(A) DC were left untreated (un) or stimulated for 17 hr with 10 ng/ml LPS, 1 mM
CpG, or 10 mg/ml poly(I:C). Upper panel:Hif1amRNAexpression (data indicate
mean + SEM; N = 9; n = 10; Kruskal-Wallis test with Dunn’s multiple com-
parison test; *p < 0.05, versus for untreated). Lower panel: HIF1a and actin
(representative of N = 3).
(B) After culture of DC with or without 10 ng/ml LPS for 17 hr, 5 mM ActD was
added. Hif1a mRNA levels were determined relative to time 0 of ActD treat-
ment (data indicate mean ± SEM; N = 6; n = 4–6).
Cell Repglycolytic activity, motility, invasiveness, and bacterial killing
under normoxia (Cramer et al., 2003). In dendritic cells (DC),
HIF1a supports maturation, activation, migration, and antigen
presentation (Bhandari et al., 2013; Jantsch et al., 2008; Ko¨hler
et al., 2012; Pantel et al., 2014). However, data on the molecular
mechanisms that underlie inflammation-driven, normoxic HIF1a
accumulation are sparse. In macrophages, lipopolysaccharide
(LPS)-induced HIF1a accumulation requires nuclear factor
(NF)-kB- and p42/44 MAPK-dependent transcriptional events
(Frede et al., 2006; Rius et al., 2008). In addition, LPS-triggered
reactive oxygen species (ROS) production and/or succinate
accumulation is linked with PHD inhibition in macrophages
(Nicholas and Sumbayev, 2010; Tannahill et al., 2013). However,
the mechanism by which LPS stabilizes HIF1a in DC is unknown.RESULTS
LPS-Induced HIF1a Stabilization Requires
Posttranslational Mechanisms
As demonstrated earlier (Jantsch et al., 2011), stimulation of DC
with Toll-like receptor (TLR) ligands 4 (LPS) and 9 (CpG) stabi-
lized HIF1a (Figure 1A). This was paralleled by a weak Hif1a
mRNA induction. In comparison, TLR 3 activation using poly(I:C)
significantly augmented Hif1amRNA levels but failed to stabilize
HIF1a protein. Hence, multistep processes are likely to be
involved in TLR-induced HIF1a accumulation. To examine the
role ofmRNA stability, wemeasuredHif1amRNA levels following
treatment with RNA-synthesis inhibitor actinomycin D (ActD).
Hif1a mRNA stability in LPS-treated DC was not altered, com-
pared to untreated DC (Figure 1B). In order to assess potential
posttranslational mechanisms, we silenced Hif1a in LPS-stimu-
lated DC (Figure 1C). In this situation, Hif1a mRNA was not(C) After culture of DC with or without 10 ng/ml LPS for 17 hr, DC were
electroporated with either non-silencing (ns) siRNA or Hif1a-specific siRNA.
After an additional 6 hr, the Hif1a mRNA expression level (data indicate
mean ± SEM; N = 3; unpaired Student’s t test; *p < 0.05) and the HIF1a and
actin levels were determined (representative of N = 4).
(D) DC were electroporated with ns siRNA or Hif1a-specific siRNA and sub-
sequently cultured with or without 10 ng/ml LPS for 17 hr. Hif1a mRNA
expression (data indicate mean ± SEM; N = 5; unpaired Student’s t test; *p <
0.05), HIF1a, and actin (representative of N = 4) levels are shown.
(E) DC were cultured with or without 10 ng/ml LPS for 17 hr under normoxic or
hypoxic (0.5% O2) conditions. PHD1–3 and VHL protein levels are shown.
Either actin or non-specific (n.s.) bands of the respective antibody were used
to demonstrate equal loading (representative of N = 2).
(F) DC were left untreated or stimulated with either 10 ng/ml LPS or 100 mM
DFO for 17 hr. Using the radiolabeled HIF1a-ODD domain, relative PHD ac-
tivity of the lysates was determined with or without addition of cofactors. PHD
activity is given in relation to the respective maximal enzymatic activity (in
presence of all co-factors, including iron) after normalization to untreated
controls (data indicate mean + SEM; N = 4; n = 6; Kruskal-Wallis test with
Dunn’s multiple comparison test; *p < 0.05).
(G) DC were cultured with or without 10 ng/ml LPS for 20 hr under normoxic or
hypoxic conditions (0.5%O2). Where indicated, 100 mMMG132 was added for
the final 4 hr. HIF1a hydroxylated at P402 and P564, total HIF1a, and actin
levels are shown (representative of N = 5).
(H) Luciferase activity (light units, L.U.) was determined in DC generated from
ODD-Luc mice unstimulated (un) or stimulated with 10 ng/ml LPS for 17 hr
(mean + SEM; N = 6; n = 22; Mann-Whitney test; *p < 0.05).
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required to maintain HIF1a on the protein level (Figure 1C). Vice
versa, silencing ofHif1a before the LPS challenge interfered with
HIF1a accumulation (Figure 1D). Hence,Hif1amRNA expression
is necessary but not sufficient for LPS-induced HIF1a stabiliza-
tion, which requires additional posttranslational mechanisms.
In DC, either LPS or hypoxia, or both, induced PHD2 and
PHD3 on the protein level (Figure 1E). Furthermore, LPS did
not negatively affect the abundance of PHD1 and VHL (Fig-
ure 1E). Hence, LPS-induced HIF1a accumulation is not the
result of reduced PHD or VHL protein levels.
Given the central role of PHD in the posttranslational regula-
tion of HIF1a, we hypothesized that LPS stimulation might inter-
fere with enzymatic PHD activity. Hence, we compared the PHD
activity of DC treated with LPS and the iron (Fe) chelator desfer-
rioxamine (DFO). DFO impairs PHD activity by chelating the en-
zyme’s critical cofactor Fe (reviewed in Greer et al., 2012). Using
the radiolabeled HIF1a-ODD domain, the percentages of the
maximum relative PHD activities of lysates were determined by
calculating the ratio of the respective PHD activity in the pres-
ence or absence of all required cofactors, including Fe. LPS
and DFO were comparably effective in reducing PHD enzyme
activity (Figure 1F; PDFO versus LPS > 0.99). This was paralleled
by impaired P402 and P564 hydroxylation of HIF1a (Figure 1G).
LPS-induced PHD inhibition was confirmed in DC derived from
genetically engineered mice having the ODD domain fused to a
luciferase gene (ODD-Luc; Safran et al., 2006). LPS treatment
augmented light emission (Figure 1H), again suggesting reduced
PHD activity. Importantly, we excluded exhaustion of PHD activ-
ity through endogenous LPS-induced HIF1a accumulation.
Silencing Hif1a using small interfering RNA (siRNA) duplexes
that do not target ODD-domain-encoding sequences reduced
LPS-induced HIF1a accumulation, whereas increased light
emission from ODD-Luc-derived DC following LPS challenge
was detectable (Figure S1). Taken together, LPS stimulation
reduced PHD activity and subsequent HIF1a hydroxylation.
LPS-Induced PHD Inhibition Is Not Caused byDeficiency
of PHD Cosubstrates or Inhibitory Endogenous
Metabolites
Next, we tried to identify the factor that impeded PHD activity in
LPS-stimulated DC. PHD activity requires a-ketoglutarate (aKG)
and O2 as substrates and Fe as a cofactor (reviewed in Greer
et al., 2012) (Figure 2A). By competing with aKG, the tricarboxylic
acid cycle (TCA) intermediates fumarate and succinate act as
PHD inhibitors. Furthermore, ROS and reactive nitrogen species
(RNS) negatively affect PHD activity (reviewed in Greer et al.,
2012).
Given that monolayers of cells cultured under normoxic condi-
tions can experience hypoxia, depending on the cell culture con-
ditions (Doege et al., 2005), we assessed the O2 levels of our cell
culture system by using luminescence optical O2 imaging. In
contrast to hypoxic controls, LPS did not lower the oxygen con-
centration at the bottom of the cell culture dish excluding LPS-
triggered O2 depletion (Figure 2B).
LPS stimulation did not deplete the PHD substrate aKG (Fig-
ure 2C), and supplementation of aKG (Figure S2A) did not affect
LPS-induced HIF1a stabilization (Figure 2D). LPS increased
fumarate and succinate levels in DC (Figures 2E and 2F). How-2050 Cell Reports 13, 2048–2055, December 15, 2015 ª2015 The Auever, raising fumarate levels in DC with dimethylfumarate (Fig-
ure S2B) did not induce HIF1a accumulation (Figure 2G).
Elevation of succinate levels brought about by a succinate dehy-
drogenase inhibitor (malonate; Figure S2C) did not enhance
HIF1a levels in DC (Figure 2H).
Endogenous ROS and exogenous RNS are known to inhibit
PHD activity (Metzen et al., 2003; Nicholas and Sumbayev,
2010). Notably, LPS stimulation resulted in ROS and RNS pro-
duction by DC (Figures 2I and 2J). Pretreatment with the ROS
scavenger N-acetyl cysteine (NAC) impaired LPS-induced ROS
production (Figure 2I) but did not block HIF1a accumulation (Fig-
ure 2K). In line with earlier findings (Metzen et al., 2003), we
observed that LPS-triggered HIF1a accumulation was partially
reduced in DC treated with the inducible nitric oxide (NO)
synthase 2 (Nos2) inhibitor L-NIL (Figures 2L and S2D). NOS2
ablation (Nos2/) had the same effect, regardless of the pres-
ence or absence of the phagocyte NADPH oxidase (gp91phox,
cytochrome b-245 b chain; Cybb/; Figure 2M). Importantly,
LPS-induced HIF1a accumulation remained substantial in
Nos2/ or L-NIL-treated DC, suggesting additional regulatory
mechanisms.
LPS Activation Depletes the Available Intracellular Iron
Pools and Impairs PHD Activity
Next, we assessed the levels of cellular Fe and its impact on
LPS-induced HIF1a stabilization. Compared to controls, LPS
stimulation did not reduce total cellular Fe levels (Figure 3A).
However, gel retardation assays demonstrated that LPS stimula-
tion increased binding of iron-regulatory proteins (IRPs) to a ra-
diolabeled iron responsive element (IRE) RNA probe (Figure 3B),
indicative of reduced cytosolic Fe availability (Hentze et al.,
2010). This was confirmed by assays that use the ability of Fe
to quench calcein fluorescence. LPS stimulation enhanced the
quenchable iron pool and, hence, is linked to a depletion of intra-
cellular available Fe (Figure 3C).
Accordingly, exogenous addition of Fe(II)Cl2 blunted LPS-
induced HIF1a accumulation in a dose-dependent manner
(Figure 3D). Similar results were obtained for Fe(III)Cl3 or ferric
ammonium citrate (FAC) (Figure S3A). Besides abolishing LPS-
induced HIF1a accumulation, Fe(II)Cl2 addition impaired LPS-
induced upregulation of MHCII and co-stimulatory molecules
(Figure S3B). This observation conforms to findings that HIF1a
promotes LPS-induced maturation of DC (Bhandari et al.,
2013; Jantsch et al., 2008). Of note, the addition of Fe(II)Cl2
also interfered with LPS-induced HIF1a accumulation in mouse
macrophages or human monocytic THP-1 cells (Figures S3C
and S3D).
Treatment with the lipophilic aKG-analog PHD inhibitor ICA or
injection of LPS induced HIF1a accumulation in splenic DC
in vivo (Figure 3E). In line with our in vitro findings, pretreatment
of mice with Fe(III)-gluconate reduced LPS-induced HIF1a accu-
mulation in splenic DC (Figure 3E).
The iron-mediated reduction of HIF1a accumulation was par-
alleled by restored hydroxylation of HIF1a at P402 andP564 (Fig-
ure 3F). Furthermore, the addition of Fe(II)Cl2 to LPS-stimulated
ODD-Luc-derived DC blocked LPS-induced light emission, indi-
cating restoration of PHD activity (Figure S3E). The PHD inhibitor
ICA extinguished the effect of Fe(II)Cl2 on LPS-induced HIF1athors
Figure 2. LPS-Induced PHD Inhibition Is Not Caused by Deficiency
of PHD Cosubstrates or Accumulation of Inhibitory Endogenous
Metabolites
(A) Schematic overview of PHD-dependent HIF1a regulation.
(B) DC were cultured with or without 10 ng/ml LPS under20%O2 (N) or 0.5%
O2 (H). O2 was detected at the bottom of plates (mean; N = 4; n = 5).
(C) DC were cultured with or without 10 ng/ml LPS for 17 hr, and aKG levels
were determined (mean + SEM; N = 4; n = 17–18; unpaired Student’s t test). un,
untreated.
(D) DC were cultured as described in (C). Where indicated, aKG was added.
HIF1a and actin levels are shown (representative of N = 3).
(E and F) DC were cultured as in (C), but fumarate levels (E) and succinate
levels (F) were detected (mean + SEM; N = 4; n = 17–18; unpaired Student’s t
test with Welch correction; *p < 0.05).
(G and H) DC were cultured as in (C) with or without (G) 2 mM DMF (repre-
sentative of N = 4) or (H) 1 mM malonate (representative of N = 2).
(I) 10 mM NAC (dashed line) or untreated DC (solid line) were cultured in the
absence (black) or presence (red) of LPS (10 ng/ml). ROS levels were assessed
by flow cytometry (N = 2). Gray filled area indicates DC without ROS dye.
(J) DC were cultured as in (C), but nitrite levels in the supernatant were as-
sessed (data indicate mean + SEM; N = 10; n = 12; Mann-Whitney test; *p <
0.05). Triangle: data are not detectable.
(K) Same as in (I). HIF1a protein and actin are shown (N = 2).
(L and M) L-NIL-treated wild-type DC (N = 2) or DC from wild-type (WT),
Nos2/, or Cybb//Nos2/ (N = 4) were cultured with or without 10 ng/ml
LPS. All cells used in (L) are from wild-type animals. HIF1a and actin levels
are shown.
Cell Repaccumulation (Figure 3G). In untreated Phd2/ and Phd2/3/
DC, HIF1a was detectable and was enhanced by LPS stimula-
tion (Figure S3F). The addition of Fe(II)Cl2 had only marginal ef-
fects on HIF1a levels in Phd2-deficient DC and was completely
ineffective in Phd2/3-deficient DC (Figure S3F).
LPS-Induced Upregulation of FTH1 Triggers HIF1a
Stabilization
Several molecules are involved in the regulation of intracellular
available Fe in immune cells (reviewed in Nairz et al., 2014). In
DC, LPS induced the expression of the antimicrobial Fe-scav-
enging molecule Lipocalin-2 (LCN2) (Figure 4A), which is also
involved in reducing intracellular available Fe pools (reviewed
in Nairz et al., 2014). However, in Lcn2/ DC, LPS-induced
HIF1a accumulation remained unaffected (Figure 4B).
Ferroportin-1 (SLC40a1) is the only known Fe export protein
(reviewed in Nairz et al., 2014). In line with unaltered total cellular
Fe content in LPS-treated DC, SLC40a1 levels were not affected
by LPS stimulation in DC (Figure S4A). Hence, it is unlikely that
LPS-induced HIF1a accumulation is based on SLC40a1-medi-
ated Fe export. Nevertheless, the silencing of basal SLC40a1
protein expression slightly reduced LPS-triggered HIF1a levels,
supporting our findings that available intracellular Fe content
plays an important role in LPS-induced HIF1a accumulation
(Figure S4B).
Natural-resistance-associated macrophage protein 1
(SLC11a1) is thought to deplete available Fe in cells (reviewed
in Nairz et al., 2014). SLC11a1-dependent Fe depletion has
been implicated in HIF1a accumulation in monocytes (Knowles
et al., 2006). LPS stimulation induced expression of Slc11a1 in
DC (Figure S4C). Nevertheless, a role for SLC11a1 in our model
system is unlikely, because we generated DC from C57BL/6
mice harboring a homozygous mutation in both Slc11a1 allelesorts 13, 2048–2055, December 15, 2015 ª2015 The Authors 2051
Figure 3. LPS-Induced Reduction of Intracellular Fe Availability Im-
pairs PHD Activity and Allows for HIF1a Accumulation
(A) Atomic absorption spectroscopy of lysates derived from DC cultured with
or without 10 ng/ml LPS for 17 hr (data indicate mean + SEM; N = 3; n = 6;
unpaired Student’s t test). un, untreated.
(B) IRE-binding activity was assessed in DC cultured with 160 mM Fe(II)Cl2,
100 mM DFO, or 10 ng/ml LPS (N = 4).
(C) DC were treated with or without LPS for 17 hr. Untreated (gray line) or
LPS-stimulated (black line) DC were loaded with calcein-AM, and geometric
mean fluorescence (given in brackets) was determined before (solid line) and
after (dashed line) the addition of Fe(II)Cl2/8-hydroxyquinoline. The quench-
able intracellular iron pool was calculated (data indicate mean + SEM; N = 2;
n = 9–10; unpaired Student’s t test with Welch correction; *p < 0.05).
(D) DC were cultured with or without 10 ng/ml LPS in the presence of
increasing Fe(II)Cl2 concentrations (0.8–160 mM) for 17 hr (one of four similar
experiments is displayed).
(E) Left panel: mice were treated with or without PHD inhibitor (ICA) for 3 hr.
Intracellular staining of HIF1a in splenic DC is given (N = 2). Right: mice were
treated with or without 10 mg Fe(III)-gluconate (Fe) followed by 30 mg LPS for
3 hr. Intracellular staining of HIF1a in splenic DC is given (representative of
N = 4).
(F) DC cultured with or without 10 ng/ml LPS and with or without 160 mM Fe(II)
Cl2 for 20 hr. Where indicated, 100 mM MG132 was added for the final 4 hr.
2052 Cell Reports 13, 2048–2055, December 15, 2015 ª2015 The Au(G169D) that disturbs SLC11a1-mediated iron transport (re-
viewed in Nairz et al., 2014).
In macrophages, LPS induces the expression of the Fe stor-
age protein ferritin heavy chain 1 (FTH1) (Kim and Ponka,
2000), which depletes available cytoplasmic Fe pools (Epsztejn
et al., 1999). In DC, LPS treatment enhanced the expression of
Fth1 both at the mRNA level (Figure 4C) and protein level (Fig-
ure 4D), which was associated with commensurate increases
in HIF1a protein levels (Figure 4D). FTH1 stimulation occurred
in spite of a concomitant increase in IRP activity (Figure 3B).
While IRP ablation in DC expectedly increased basal FTH1
protein levels, it did not prevent FTH1 stimulation by LPS (Fig-
ure S4D). Hence, LPS regulation of FTH1 in DC is largely inde-
pendent of the IRP/IRE system and could reflect alternative
IRP-independent regulation of FTH1 as, for instance, observed
in fibrosarcoma cells (Daba et al., 2012). Pharmacological inhibi-
tion of NF-kB activity abolished LPS-triggered FTH1 induction,
HIF1a accumulation, and LPS-induced NO production (Fig-
ure 4E). Silencing of Fth1 did not affect LPS-triggered increases
in Hif1a mRNA levels but reduced HIF1a protein accumulation
(Figure 4F). This was paralleled by reduced expression of in-
flammatory (Nos2) and glycolytic (Pgk1 and Slc2a1 [or Glut1])
HIF1a-target genes (Figures 4F and S4E). Upon Fth1 or Hif1a
silencing, expression of an NF-kB response gene Tnfaip3 (A20)
(Coornaert et al., 2009) and triacylglycerol scavenger receptor
(CD36) linked to alternative activation of myeloid cells (Huang
et al., 2014) remained unchanged (Figure S4E). Moreover,
Hif1a silencing impaired NOS2 expression but did not affect
LPS-triggered FTH1 induction, which excludes regulation of
FTH1 by HIF1a (Figure 4F). These data demonstrate that FTH1
is required for LPS-induced HIF1a accumulation. Finally, we
treated Fth1-silenced DC with the Fe chelator DFO. DFO
mimicked the effect of FTH1 induction by LPS and restored
HIF1a accumulation in Fth1-silenced DC (Figure 4G). Altogether,
we conclude, that LPS-triggered, NF-kB-dependent FTH1 upre-
gulation depletes available cellular Fe. Lack of this co-factor re-
sults in impaired PHD activity and allows for normoxic HIF1a
stabilization.
DISCUSSION
Regulation of Fe availability is crucial in innate immune defense
(reviewed in Nairz et al., 2014). Withholding Fe from invading
pathogens efficiently contributes to the control of infections by
nutrient deprivation. Conversely, excess availability of Fe favors
pathogen replication and impairs certain immune responses
such as NO production (Weiss et al., 1994) and the capability
of antigen presentation (Carrasco-Marı´n et al., 1996).
In epithelial cells, microbial Fe-chelating compounds (sidero-
phores) inhibit HIF1a hydroxylation and result in subsequent
normoxic HIF1a stabilization (Hartmann et al., 2008). In DC, the
microbial cell wall component LPS suppresses endogenousHydroxylated HIF1a at P402, hydroxylated HIF1a at P564, total HIF1a, and
actin (representative of N = 4) levels are shown.
(G) DC were cultured with or without 10 ng/ml LPS in the absence or presence
of 100 mM ICA ± 80 mM Fe(II)Cl2 for 17 hr. HIF1a and actin levels are shown
(representative of N = 2).
thors
Figure 4. LPS-Induced Upregulation of the Fe Storage Protein FTH1
Triggers HIF1a Stabilization
(A) DC were cultured with or without 10 ng/ml LPS. Lcn2 mRNA levels were
measured at indicated time points (data indicate mean ± SEM; N = 2; n = 4–6).
un, untreated.
(B) DC derived from Lcn2/ and littermates were cultured with or without
10 ng/ml LPS. HIF1a and actin levels are shown (N = 3).
(C) DC were cultured as in (A). Fth1 mRNA expression levels are shown (data
indicate mean ± SEM; N = 2; n = 2–6).
(D) DC were cultured with or without 10 ng/ml LPS. HIF1a, FTH1, and actin
levels are shown (N = 3).
(E) DCwere pretreatedwith 40 mMBAY11-7085 (BAY11) or left untreated. After
1 hr, DC were cultured with or without 10 ng/ml LPS for 17 hr. Upper panel:
nitrite levels in the supernatant are shown (N = 2; n = 5). Lower panel: HIF1a,
FTH1, and actin levels are shown (N = 2).
(F) DC electroporated with non-silencing (ns)-, Hif1a-, or Fth1-specific siRNA
were cultured ± 10 ng/ml LPS for 17 hr. Upper panel: Hif1a mRNA expression
levels are shown (data indicate mean ± SEM; N = 3; n = 2–3). Lower panels:
HIF1a, NOS2, FTH1, and actin levels are shown (N = 4).
Cell Repiron availability via the induction of ferritin, resulting in subse-
quent PHD inhibition and HIF1a stabilization. In addition to
HIF1a stabilization, LPS-triggered inhibition of PHD activity
might have broader consequences in innate immune cells,
because prolyl hydroxylation sites are not only present in
HIF1a but also occur in several other proteins involved in NF-
kB signal transduction and interleukin (IL)-1b signaling (Cummins
et al., 2006; Scholz et al., 2013).
Inflammatory (LPS-triggered) and canonical (hypoxia-driven)
HIF1a stabilization are both dependent on PHD inhibition. How-
ever, while hypoxia reduces PHD activity due to a lack of oxygen,
LPS blocks PHD activity through deprivation of the essential
cofactor Fe. HIF1a stabilization plays an important role in the
proinflammatory activation of innate immune cells and their abil-
ity to combat infections and to regulate adaptive immune re-
sponses (Palazon et al., 2014). However, in contrast to infectious
diseases, reduced HIF1a stabilization in innate immune cells
might be desirable in inflammation-driven pathological condi-
tions. Given that TLR4 signaling and inflammatory HIF1a are
implicated in the pathology of autoimmune diseases such
as rheumatoid arthritis (Cramer et al., 2003), our dissection
of LPS-induced signaling pathways that result in HIF1a stabi-
lization might be exploited for new therapeutic approaches
that selectively target inflammatory HIF1a activation without
affecting hypoxic HIF1a stabilization, which is critically required
for adaption of cells to low-oxygen conditions.
EXPERIMENTAL PROCEDURES
Generation of DC, RNAi, Immunoblotting, qPCR, NO, and ROS
Production
DC and macrophages were generated from the bone marrow of C57BL/6,
ODD-Luc, Nos2/, Cybb/Nos2/, Lcn2/, LysMCre Phd2fl/fl, LysMCre
Phd2/3fl/fl, and LysMCre Irp1/2fl/fl mice. RNAi, immunoblotting, and qPCR
were performed as described previously (Jantsch et al., 2011). Nitrite and
ROS production were assessed by Griess reaction and after staining with
CM-H2DCFDA, respectively.
Luciferase Activity
DC were lysed with a suitable lysis buffer and processed with luciferase sub-
strate. Luminescence was detected with a TopCount NTX reader.
Determination of Total Intracellular Iron Content by Atomic
Absorption Spectroscopy and Gel Retardation Assays
Total cellular iron content was quantified with a Shimadzu AA-7000 atomic ab-
sorption spectrophotometer. IRE/IRP complexes were analyzed by nondena-
turing gel electrophoresis and autoradiography after incubation with an in vitro
transcribed 32P-labeled IRE probe. The labile iron pool was quantified by using
the property of Fe(II) to quench the fluorescence of calcein. The quenchable
iron pool was calculated by substracting the geometric mean fluorescence
of (un)stimulated cells before and after incubation with Fe(II)Cl2/8-hydroxyqui-
noline. The greater the quenchable iron pool, the smaller the intracellular avail-
able Fe.
Oxygen Consumption with Oxodish and SDR SensorDish Reader
In order to quantify oxygen levels in cell culture plates, we used precalibrated
OxoDish six-well plates. Signals were generated and detected by SDR
SensorDish and SDR software.(G) DC electroporated with non-silencing (ns)- or Fth1-specific siRNA were
cultured with or without 10 ng/ml LPS and treated with 100 mM DFO for 17 hr
(N = 2).
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Analysis of TCA Intermediates by HPLC-MS/MS
Cell pellets were spiked with internal standard solution containing [U-13C]
fumarate, [U-2H]succinate, and [U-2H]a-ketoglutarate. Pellets were analyzed
by high-pressure liquid chromatography/electrospray ionization/tandem
mass spectrometry (HPLC-ESI-MS/MS), using multiple reaction monitoring
and negative mode ionization. Quantification was performed using calibration
curves, with the corresponding stable isotope-labeled analogs as internal
standards.
Analysis of HIF1a in Spleen DC
C57BL/6 mice were injected intraperitoneally (i.p.) with either ICA in vehicle or
vehicle alone, and with Fe(III)-gluconate in PBS or PBS alone, followed after
1 hr by injection of either LPS in PBS or PBS alone. 3 hr later, splenic single-
cell suspensions were prepared, and intracellular HIF1a was analyzed by
flow cytometry in DC. All animal experiments were carried out according to
protocols approved by the Animal Welfare Committee of the local government
(Regierung von Mittelfranken).
Statistical Analysis
Results are expressed as means ± SEM. If not indicated otherwise, n repre-
sents biological samples obtained from N independent experiments or mice.
Statistical significance was calculated with Prism v6.0 (GraphPad Software).
Further detailed information is in the Supplemental Experimental
Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.11.005.
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